Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
GlaxoSmithKline
David J Jackson; Michael E Wechsler; Daniel J Jackson; David Bernstein; Stephanie Korn; Paul E Pfeffer; Ruchong Chen; Junpei Saito; Gustavo de Luíz Martinez; Lucyna Dymek; Loretta Jacques; Nicholas Bird; Stein Schalkwijk; Douglas Smith; Peter Howarth; Ian D Pavord; SWIFT-1 and SWIFT-2 Investigators; SWIFT-1 Investigators; SWIFT-2 Investigators